Search

Edward H Kislauskis

from Duxbury, MA
Age ~64
Get Report
Also known as:
Edward D Kislauskis, Ed H Kislauskis, Edward I
Related to:
William J Mcavoy, 60
Connected to:
Lemlem Kislemariam, 71Tautia A Kisler, 57Erik L Kislesky, 49Brain P Kislia, 56Carrie B Kislin, 45Justin A Kislin, 33Arley T Kisling, 79Donovan M Kisling, 53Jonathan S Kislingbury, 54Laurie B Kisling, 63

Edward Kislauskis Phones & Addresses

  • Duxbury, MA
  • 2 Nobscott Rd, Medway, MA 02053 (508) 533-1459 (508) 533-2178
  • Plymouth, MA
  • 19 Bay View Ave, Kingston, MA 02364 (781) 585-6607 (781) 936-8240
  • 36 Finnell Dr STE 1, Weymouth, MA 02188
  • Worcester, MA
  • 2 Nobscott Rd, Medway, MA 02053 (508) 631-2160

Work

Company: Survival solutions Mar 2017 Position: Vice president, co-founder

Education

School / High School: Worcester Polytechnic Institute 2004 to 2005 Specialities: Management

Skills

Biotechnology • Drug Development • Pharmaceutical Industry • Oncology • Commercialization • Cro • R&D • Clinical Research • Life Sciences • Drug Discovery • Medical Devices • Clinical Development • Project Management • Program Management • Glp • Strategic Planning • Immunology • Biopharmaceuticals • Business Development • Management Consulting • Cell Biology • Molecular Biology • Cross Functional Team Leadership • Strategic Consulting • Market Analysis • Quality System • Six Sigma • Project Risk • Analysis • Start Up Consulting • Lean Startup • Early Stage Startups • Grantsmanship • Federal Grants Management • Grant Coordination • Far Compliance • Expert Relationship Builder • Cell • Strategy • Biochemistry • Science • Animal Models • Business Strategy • Quality Assurance • Start Ups • Technology Transfer • Laboratory • Management • Leadership • Clinical Trials

Languages

English

Ranks

Certificate: Medical Device Management

Interests

Science and Technology • Education • Animal Welfare • Environment

Industries

Research

Resumes

Resumes

Edward Kislauskis Photo 1

Vice President, Co-Founder

View page
Location:
2 Nobscot Rd, Medway, MA
Industry:
Research
Work:
Survival Solutions
Vice President, Co-Founder
Trustees of Boston University Jun 2016 - Nov 2016
Senior Consultant
Phoenicia Biosciences Inc Jun 2015 - Sep 2016
Contract Consultant, Preclinical Research
Hygeia Therapeutics Jan 2008 - Dec 2013
Scientific Co-Founder
Synta Pharmaceuticals Oct 2009 - Dec 2013
Consultant, Federal Grants and Contracts
Education:
Worcester Polytechnic Institute 2004 - 2005
University of Massachusetts Medical School 1984 - 1991
Doctorates, Doctor of Philosophy, Genetics, Philosophy University of Massachusetts Amherst 1977 - 1981
Bachelors
Skills:
Biotechnology
Drug Development
Pharmaceutical Industry
Oncology
Commercialization
Cro
R&D
Clinical Research
Life Sciences
Drug Discovery
Medical Devices
Clinical Development
Project Management
Program Management
Glp
Strategic Planning
Immunology
Biopharmaceuticals
Business Development
Management Consulting
Cell Biology
Molecular Biology
Cross Functional Team Leadership
Strategic Consulting
Market Analysis
Quality System
Six Sigma
Project Risk
Analysis
Start Up Consulting
Lean Startup
Early Stage Startups
Grantsmanship
Federal Grants Management
Grant Coordination
Far Compliance
Expert Relationship Builder
Cell
Strategy
Biochemistry
Science
Animal Models
Business Strategy
Quality Assurance
Start Ups
Technology Transfer
Laboratory
Management
Leadership
Clinical Trials
Interests:
Science and Technology
Education
Animal Welfare
Environment
Languages:
English
Certifications:
Medical Device Management
Worcester Polytechnic Institute

Business Records

Name / Title
Company / Classification
Phones & Addresses
Edward Kislauskis
Principal
NEREUS LIFE SCIENCES, LLC
Business Services at Non-Commercial Site
36 Finnell Dr UNIT 1, Weymouth, MA 02188
2 Nobscott Rd, Medway, MA 02053
(781) 803-2882

Publications

Us Patents

Extended Release Analgesic For Pain Control

View page
US Patent:
6939538, Sep 6, 2005
Filed:
Apr 10, 2003
Appl. No.:
10/410940
Inventors:
Albert Prescott - Groton MA, US
Edward Kislauskis - Medway MA, US
Dennis L. Guberski - Rutland MA, US
Assignee:
Biomedical Research Models, Inc. - Worcester MA
International Classification:
A61K031/535
A61K031/74
US Classification:
424 7808, 5142312
Abstract:
An extended release analgesic for controlling pain comprised of an opioid or non-opioid analgesic drug ionically bound to hyaluronic acid, poly-γ-glutamic acid or other ionic polymers, and injected into a body either subcutaneously, intramuscularly or intraperitoneally, utilizing counter-ions of different valences to control the rate of release into the body.

Cell Separation Method And Apparatus

View page
US Patent:
8048678, Nov 1, 2011
Filed:
Jun 29, 2010
Appl. No.:
12/826074
Inventors:
Jeffrey R. Chabot - Medford MA, US
Edward H Kislauskis - Medway MA, US
Assignee:
ECW Therapeutics, Inc. - Marshfield MA
International Classification:
C02F 1/02
US Classification:
436 70, 436177, 435325, 600580, 210513, 422 58, 422918, 422939
Abstract:
Disclosed herein are apparatus and methods for isolating a fraction of interest from a physiological fluid sample. A sample holder for isolating a fraction of interest from a physiological fluid sample includes a flexible compartment and a rigid exoskeleton that supports the flexible compartment. The flexible compartment may have at least one reservoir with a height to volume ratio of about 0. 1 cm/mL to about 5 cm/mL. An automated device for extracting a fraction of interest from the sample includes a sample holder with a flexible compartment supported by a rigid exoskeleton, a support for the sample holder connected to one or more fluid extraction devices, and a motor for moving the extraction device relative to the sample holder. The automated device may include an optical sensor and may include a clamp for clamping the flexible compartment.

Cell Separation Method And Apparatus

View page
US Patent:
8241592, Aug 14, 2012
Filed:
Sep 29, 2011
Appl. No.:
13/248508
Inventors:
Jeffrey R. Chabot - Medford MA, US
Edward H. Kislauskis - Medway MA, US
Assignee:
Endocellutions, Inc. - Marshfield MA
International Classification:
C12M 1/00
US Classification:
422548, 422527, 422533, 422547, 422549, 422550, 422559, 422560, 422561, 222 94, 222105, 210513, 210515, 210516, 2105321, 600580, 436 70, 436177, 435325
Abstract:
Disclosed herein are apparatus and methods for isolating a fraction of interest from a physiological fluid sample. A sample holder for isolating a fraction of interest from a physiological fluid sample includes a flexible compartment and a rigid exoskeleton that supports the flexible compartment. The flexible compartment may have at least one reservoir with a height to volume ratio of about 0. 1 cm/mL to about 5 cm/mL. An automated device for extracting a fraction of interest from the sample includes a sample holder with a flexible compartment supported by a rigid exoskeleton, a support for the sample holder connected to one or more fluid extraction devices, and a motor for moving the extraction device relative to the sample holder. The automated device may include an optical sensor and may include a clamp for clamping the flexible compartment.

Methods For Tailoring The Immune Response To An Antigen Or Immunogen

View page
US Patent:
20060035853, Feb 16, 2006
Filed:
Jan 7, 2005
Appl. No.:
11/032487
Inventors:
Kejian Yang - Northborough MA, US
Barbara Whalen - Shrewsbury MA, US
Edward Kislauskis - Medway MA, US
Dennis Guberski - Rutland MA, US
Assignee:
Biomedical Research Models, Inc. - Worcester MA
Oral Vaccine Technologies , Inc, - Las Vegas NV
International Classification:
A61K 48/00
A61K 9/127
US Classification:
514044000, 424093200, 424450000
Abstract:
The invention relates to methods and reagents for immunizing animals to elicit specific cellular and humoral immune-responses against specific antigens, such as viral antigens, including HBsAg antigen. The invention provides methods of using specifically prepared immunogen in fresh or lyophilized liposome, proper routes of administration of the immunogen, proper doses of the immunogen, and specific combinations of heterologous immunization including DNA priming in one administration route followed by liposome-mediated protein antigen boost in a different route to tailor the immune responses in respects of enhancing cell mediated immune response, cytokine secretion, humoral immune response, immune protection and selective skewing of T helper responses to be Th1, Th2, or a mixed or balanced Th response.

Non-Human Animal Models For Diabetic Complications And Their Uses

View page
US Patent:
20060179499, Aug 10, 2006
Filed:
Aug 19, 2005
Appl. No.:
11/207315
Inventors:
Rebecca Tirabassi - Sturbridge MA, US
Edward Kislauskis - Medway MA, US
Joan Flanagan - Worcester MA, US
Dennis Guberski - Rutland MA, US
International Classification:
A01K 67/027
US Classification:
800014000
Abstract:
The instant invention relates to methods for generating a non-human animal model for a diabetic complication. The invention further relates to screening methods for therapeutics of diabetic complications using the animal model generated by the methods of the invention.

Cell Separation Method And Apparatus

View page
US Patent:
20070131612, Jun 14, 2007
Filed:
Oct 27, 2006
Appl. No.:
11/588835
Inventors:
Neil Duffy - Brighton MA, US
Jeffrey Chabot - Medford MA, US
Edward Kislauskis - Medway MA, US
International Classification:
C02F 1/02
G01N 1/18
C12N 5/00
US Classification:
210600000, 435325000, 436177000
Abstract:
Disclosed herein are apparatus and methods for isolating a fraction of interest from a physiological fluid sample.

Methods Of Cancer Treatment/Prevention Using Cancer Cell-Specific Surface Antigens

View page
US Patent:
20080267963, Oct 30, 2008
Filed:
Oct 27, 2005
Appl. No.:
11/666956
Inventors:
Edward H. Kislauskis - Medway MA, US
Kejian Yang - Northborough MA, US
Barbara J. Whalen - Shrewsbury MA, US
Assignee:
Biomedical Research Model, Inc. - Worchester MA
International Classification:
A61K 9/127
A61K 39/00
A61K 39/395
A61P 35/04
US Classification:
4241381, 424450, 4242771
Abstract:
The invention relates to methods and reagents for immunizing and treating individual with cancer to elicit specific cellular and humoral immune-responses against specific cancer cell surface antigens, including those cancer cell surface antigens expressed only in cancer cells and in non-cancer cells normally located in one or more immune-privileged sites or tissues of the individual. The invention provides methods of using specifically prepared immunogen in fresh or lyophilized liposome, proper routes of administration of the immunogen, proper doses of the immunogen, and specific combinations of heterologous immunization including DNA priming in one administration route followed by liposome-mediated protein antigen boost in a different route to tailor the immune responses in respects of enhancing cell mediated immune response, cytokine secretion, humoral immune response, especially skewing T helper responses to be Th1 or a balanced Th1 and Th2 type.

Cis-Acting Sequences For Intracellular Localization Of Rna

View page
US Patent:
56416750, Jun 24, 1997
Filed:
Oct 7, 1994
Appl. No.:
8/319836
Inventors:
Robert H. Singer - Shrewsbury MA
Edward H. Kislauskis - Kingston MA
Assignee:
University of Massachusetts Medical Center - Worcester MA
International Classification:
C12N 500
G07H 2104
US Classification:
435325
Abstract:
Disclosed are the particular 3' noncoding nucleotide sequences (zipcode and zipcode elements) that cause. beta. -actin mRNA (and. beta. -actin protein synthesis) to be localized in specific regions of the cytoplasm. Also disclosed is the discovery that zipcode function can be fully inhibited by antisense oligonucleotides.
Control profile
Edward H Kislauskis from Duxbury, MA, age ~64 Get Report